Zhejiang Hisoar Pharmaceutical Co Ltd Total Assets
Zhejiang Hisoar Pharmaceutical Co Ltd total assets. Based on the latest financial reports, Zhejiang Hisoar Pharmaceutical Co Ltd (002099) holds total assets worth CN¥7.28 Billion CNY (≈ $1.06 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 002099 company net worth for the company's overall valuation and market capitalisation.
Total Assets of Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)
Total assets of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024. This chart illustrates how Zhejiang Hisoar Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. See 002099 stock price and chart for real-time trading data and today's change.
Zhejiang Hisoar Pharmaceutical Co Ltd - Asset Composition Analysis
Zhejiang Hisoar Pharmaceutical Co Ltd Total Assets Breakdown (December 2024)
Zhejiang Hisoar Pharmaceutical Co Ltd total assets breakdown as of December 2024. Zhejiang Hisoar Pharmaceutical Co Ltd's total assets of CN¥7.28 Billion consist of 38.8% current assets and 61.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 20.4% |
| Accounts Receivable | CN¥467.09 Million | 6.3% |
| Inventory | CN¥799.71 Million | 10.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥520.43 Million | 7.0% |
| Goodwill | CN¥394.84 Million | 5.3% |
Asset Composition Trend (2003–2024)
This chart illustrates how Zhejiang Hisoar Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 002099 working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Hisoar Pharmaceutical Co Ltd's current assets represent 38.8% of total assets in 2024, a decrease from 63.0% in 2003.
- Cash Position: Cash and equivalents constituted 20.4% of total assets in 2024, up from 11.5% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 1.0% in 2003.
- Asset Diversification: The largest asset category is inventory at 10.7% of total assets.
Zhejiang Hisoar Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Hisoar Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
|
China | CN¥9.54 Billion |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
|
China | CN¥6.44 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Bide Pharmatech Co. Ltd. A
SHG:688073
|
China | CN¥2.54 Billion |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
|
China | CN¥4.69 Billion |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
|
China | CN¥2.26 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥25.73 Billion |
Zhejiang Hisoar Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.38 | 1.35 | 2.74 |
| Quick Ratio | 0.95 | 0.96 | 2.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥799.81 Million | CN¥721.17 Million | CN¥2.06 Billion |
Zhejiang Hisoar Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Hisoar Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.36 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | -0.9% |
| Total Assets | CN¥7.46 Billion |
| Market Capitalization | $1.34 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Hisoar Pharmaceutical Co Ltd's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Zhejiang Hisoar Pharmaceutical Co Ltd's assets decreased by 0.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)
The table below shows the annual total assets of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥7.46 Billion ≈ $1.09 Billion |
-0.85% |
| 2023-12-31 | CN¥7.52 Billion ≈ $1.10 Billion |
-10.40% |
| 2022-12-31 | CN¥8.39 Billion ≈ $1.23 Billion |
+4.65% |
| 2021-12-31 | CN¥8.02 Billion ≈ $1.17 Billion |
+11.72% |
| 2020-12-31 | CN¥7.18 Billion ≈ $1.05 Billion |
+6.39% |
| 2019-12-31 | CN¥6.75 Billion ≈ $987.33 Million |
-4.10% |
| 2018-12-31 | CN¥7.04 Billion ≈ $1.03 Billion |
-5.78% |
| 2017-12-31 | CN¥7.47 Billion ≈ $1.09 Billion |
+8.13% |
| 2016-12-31 | CN¥6.91 Billion ≈ $1.01 Billion |
+42.95% |
| 2015-12-31 | CN¥4.83 Billion ≈ $706.89 Million |
+15.92% |
| 2014-12-31 | CN¥4.17 Billion ≈ $609.83 Million |
+97.55% |
| 2013-12-31 | CN¥2.11 Billion ≈ $308.69 Million |
+9.99% |
| 2012-12-31 | CN¥1.92 Billion ≈ $280.67 Million |
+33.65% |
| 2011-12-31 | CN¥1.44 Billion ≈ $210.01 Million |
+25.85% |
| 2010-12-31 | CN¥1.14 Billion ≈ $166.86 Million |
+14.46% |
| 2009-12-31 | CN¥996.27 Million ≈ $145.79 Million |
-1.66% |
| 2008-12-31 | CN¥1.01 Billion ≈ $148.24 Million |
+6.67% |
| 2007-12-31 | CN¥949.75 Million ≈ $138.98 Million |
+3.02% |
| 2006-12-31 | CN¥921.93 Million ≈ $134.91 Million |
+59.86% |
| 2005-12-31 | CN¥576.72 Million ≈ $84.39 Million |
+48.88% |
| 2004-12-31 | CN¥387.38 Million ≈ $56.69 Million |
+6.90% |
| 2003-12-31 | CN¥362.38 Million ≈ $53.03 Million |
-- |
About Zhejiang Hisoar Pharmaceutical Co Ltd
Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical… Read more